Stock Analysis on Net
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Adjusted Financial Ratios

Microsoft Excel

Adjusted Financial Ratios (Summary)

Cytokinetics Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Activity Ratio
Total Asset Turnover
Reported 0.09 0.08 0.10 0.09 0.15
Adjusted 0.01 0.08 0.27 0.09 0.14
Solvency Ratios
Debt to Equity
Reported — 0.59 1.20 — 1.64
Adjusted — 0.82 0.69 — 2.03
Debt to Capital
Reported 1.21 0.37 0.54 1.09 0.62
Adjusted 1.17 0.45 0.41 1.09 0.67
Financial Leverage
Reported — 3.45 4.71 — 8.14
Adjusted — 2.54 2.66 — 8.54
Profitability Ratios
Net Profit Margin
Reported -411.21% -305.72% -228.00% -452.93% -337.41%
Adjusted -6,308.33% -307.17% -28.58% -452.26% -336.92%
Return on Equity (ROE)
Reported — -88.29% -112.27% — -409.84%
Adjusted — -65.38% -20.37% — -409.24%
Return on Assets (ROA)
Reported -38.33% -25.59% -23.85% -41.99% -50.33%
Adjusted -47.17% -25.71% -7.65% -41.93% -47.91%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Financial ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Cytokinetics Inc. adjusted total asset turnover ratio deteriorated from 2020 to 2021 and from 2021 to 2022.
Adjusted debt-to-capital ratio A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Cytokinetics Inc. adjusted debt-to-capital ratio deteriorated from 2020 to 2021 and from 2021 to 2022.
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by total revenue. Cytokinetics Inc. adjusted net profit margin ratio deteriorated from 2020 to 2021 and from 2021 to 2022.
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Cytokinetics Inc. adjusted ROA deteriorated from 2020 to 2021 and from 2021 to 2022.

Cytokinetics Inc., Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Revenues 94,588 70,428 55,828 26,868 31,501
Total assets 1,014,775 841,319 533,803 289,814 211,178
Activity Ratio
Total asset turnover1 0.09 0.08 0.10 0.09 0.15
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted revenues2 7,588 70,428 142,828 26,868 31,501
Adjusted total assets3 1,014,775 841,319 533,803 289,814 221,533
Activity Ratio
Adjusted total asset turnover4 0.01 0.08 0.27 0.09 0.14

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Total asset turnover = Revenues ÷ Total assets
= 94,588 ÷ 1,014,775 = 0.09

2 Adjusted revenues. See details »

3 Adjusted total assets. See details »

4 2022 Calculation
Adjusted total asset turnover = Adjusted revenues ÷ Adjusted total assets
= 7,588 ÷ 1,014,775 = 0.01

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Cytokinetics Inc. adjusted total asset turnover ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Adjusted Debt to Equity

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Total debt 611,619 144,143 135,713 129,257 42,413
Stockholders’ equity (deficit) (107,900) 243,863 113,383 (10,937) 25,934
Solvency Ratio
Debt to equity1 — 0.59 1.20 — 1.64
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 751,343 271,235 138,938 136,068 52,768
Adjusted stockholders’ equity (deficit)3 (107,900) 330,863 200,383 (10,937) 25,934
Solvency Ratio
Adjusted debt to equity4 — 0.82 0.69 — 2.03

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity (deficit)
= 611,619 ÷ -107,900 = —

2 Adjusted total debt. See details »

3 Adjusted stockholders’ equity (deficit). See details »

4 2022 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted stockholders’ equity (deficit)
= 751,343 ÷ -107,900 = —

Adjusted Debt to Capital

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Total debt 611,619 144,143 135,713 129,257 42,413
Total capital 503,719 388,006 249,096 118,320 68,347
Solvency Ratio
Debt to capital1 1.21 0.37 0.54 1.09 0.62
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 751,343 271,235 138,938 136,068 52,768
Adjusted total capital3 643,443 602,098 339,321 125,131 78,702
Solvency Ratio
Adjusted debt to capital4 1.17 0.45 0.41 1.09 0.67

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Debt to capital = Total debt ÷ Total capital
= 611,619 ÷ 503,719 = 1.21

2 Adjusted total debt. See details »

3 Adjusted total capital. See details »

4 2022 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= 751,343 ÷ 643,443 = 1.17

Solvency ratio Description The company
Adjusted debt-to-capital ratio A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Cytokinetics Inc. adjusted debt-to-capital ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Total assets 1,014,775 841,319 533,803 289,814 211,178
Stockholders’ equity (deficit) (107,900) 243,863 113,383 (10,937) 25,934
Solvency Ratio
Financial leverage1 — 3.45 4.71 — 8.14
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total assets2 1,014,775 841,319 533,803 289,814 221,533
Adjusted stockholders’ equity (deficit)3 (107,900) 330,863 200,383 (10,937) 25,934
Solvency Ratio
Adjusted financial leverage4 — 2.54 2.66 — 8.54

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity (deficit)
= 1,014,775 ÷ -107,900 = —

2 Adjusted total assets. See details »

3 Adjusted stockholders’ equity (deficit). See details »

4 2022 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted stockholders’ equity (deficit)
= 1,014,775 ÷ -107,900 = —

Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Net loss (388,955) (215,314) (127,290) (121,692) (106,289)
Revenues 94,588 70,428 55,828 26,868 31,501
Profitability Ratio
Net profit margin1 -411.21% -305.72% -228.00% -452.93% -337.41%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net loss2 (478,676) (216,332) (40,820) (121,513) (106,132)
Adjusted revenues3 7,588 70,428 142,828 26,868 31,501
Profitability Ratio
Adjusted net profit margin4 -6,308.33% -307.17% -28.58% -452.26% -336.92%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Net profit margin = 100 × Net loss ÷ Revenues
= 100 × -388,955 ÷ 94,588 = -411.21%

2 Adjusted net loss. See details »

3 Adjusted revenues. See details »

4 2022 Calculation
Adjusted net profit margin = 100 × Adjusted net loss ÷ Adjusted revenues
= 100 × -478,676 ÷ 7,588 = -6,308.33%

Profitability ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by total revenue. Cytokinetics Inc. adjusted net profit margin ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Net loss (388,955) (215,314) (127,290) (121,692) (106,289)
Stockholders’ equity (deficit) (107,900) 243,863 113,383 (10,937) 25,934
Profitability Ratio
ROE1 — -88.29% -112.27% — -409.84%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net loss2 (478,676) (216,332) (40,820) (121,513) (106,132)
Adjusted stockholders’ equity (deficit)3 (107,900) 330,863 200,383 (10,937) 25,934
Profitability Ratio
Adjusted ROE4 — -65.38% -20.37% — -409.24%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
ROE = 100 × Net loss ÷ Stockholders’ equity (deficit)
= 100 × -388,955 ÷ -107,900 = —

2 Adjusted net loss. See details »

3 Adjusted stockholders’ equity (deficit). See details »

4 2022 Calculation
Adjusted ROE = 100 × Adjusted net loss ÷ Adjusted stockholders’ equity (deficit)
= 100 × -478,676 ÷ -107,900 = —

Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Reported
Selected Financial Data (US$ in thousands)
Net loss (388,955) (215,314) (127,290) (121,692) (106,289)
Total assets 1,014,775 841,319 533,803 289,814 211,178
Profitability Ratio
ROA1 -38.33% -25.59% -23.85% -41.99% -50.33%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net loss2 (478,676) (216,332) (40,820) (121,513) (106,132)
Adjusted total assets3 1,014,775 841,319 533,803 289,814 221,533
Profitability Ratio
Adjusted ROA4 -47.17% -25.71% -7.65% -41.93% -47.91%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
ROA = 100 × Net loss ÷ Total assets
= 100 × -388,955 ÷ 1,014,775 = -38.33%

2 Adjusted net loss. See details »

3 Adjusted total assets. See details »

4 2022 Calculation
Adjusted ROA = 100 × Adjusted net loss ÷ Adjusted total assets
= 100 × -478,676 ÷ 1,014,775 = -47.17%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Cytokinetics Inc. adjusted ROA deteriorated from 2020 to 2021 and from 2021 to 2022.